Product Program year 2023 Source: CMS Open Payments

Photrexa Cross-Linking Kit

Drug Corneal Health

Open in the dashboard

General payments

$13,705

195 payments

Research payments

$0

0 payments

Through program year 2023, $13,705 in general payments and $0 in research payments were reported against Photrexa Cross-Linking Kit (Corneal Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $13,705 195

Breakdown

Who paid General payments · program year 2023
  1. Glaukos Corporation $13,705 195 payments
Top recipients General payments · program year 2023
  1. Douglas Katsev Ophthalmology · Santa Barbara, CA $212 2% · 2 payments
  2. Zachary Holland Optometrist · Edina, MN $211 2% · 5 payments
  3. Samantha Wang Optometrist · Houston, TX $162 1% · 2 payments
  4. Steven Israel Optometrist · Lancaster, CA $161 1% · 1 payment
  5. Robert Feinfield Ophthalmology · Burbank, CA $161 1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Ophthalmology $5,932 44% · 80 practitioners
  2. Optometrist $5,652 42% · 77 practitioners
  3. Glaucoma Specialist Ophthalmology $527 4% · 6 practitioners
  4. Optometrist, Corneal and Contact Management Optometrist $353 3% · 3 practitioners
  5. Optometrist, Vision Therapy Optometrist $261 2% · 2 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $4,924 36% · 53 recipients
  2. Texas $1,545 11% · 20 recipients
  3. North Carolina $1,251 9% · 11 recipients
  4. Missouri $531 4% · 10 recipients
  5. Georgia $468 3% · 8 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

195 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record